Comparison of a full systematic review versus rapid review approaches to assess a newborn screening test for tyrosinemia type 1
暂无分享,去创建一个
Aileen Clarke | Karoline Freeman | Paul Sutcliffe | Sian Taylor-Phillips | Chris Stinton | S. Taylor-Phillips | A. Clarke | C. Stinton | P. Sutcliffe | S. Johnson | K. Freeman | J. Geppert | H. Fraser | Hannah Fraser | Julia Geppert | Samantha Johnson
[1] T. Zytkovicz,et al. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. , 2004, Clinical biochemistry.
[2] David Hailey,et al. RAPID VERSUS FULL SYSTEMATIC REVIEWS: VALIDITY IN CLINICAL PRACTICE? , 2008, ANZ journal of surgery.
[3] David Moher,et al. Evidence summaries: the evolution of a rapid review approach , 2012, Systematic Reviews.
[4] F. Lorey,et al. Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[5] Donna Ciliska,et al. Expediting systematic reviews: methods and implications of rapid reviews , 2010, Implementation science : IS.
[6] E. Mayatepek,et al. Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone. , 2006, Clinical chemistry.
[7] S. Taylor-Phillips,et al. Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy , 2017, Orphanet Journal of Rare Diseases.
[8] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[9] M. Caggana,et al. Newborn screening for Tyr-I: two years' experience of the New York State program. , 2011, Molecular genetics and metabolism.
[10] A. Kazanjian,et al. Evidence-based practice: extending the search to find material for the systematic review. , 2001, Bulletin of the Medical Library Association.
[11] Susan Mallett,et al. Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles , 2014, PloS one.
[12] D. Moher,et al. Scoping reviews: time for clarity in definition, methods, and reporting. , 2014, Journal of clinical epidemiology.
[13] Flemming Skovby,et al. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening. , 2012, Molecular genetics and metabolism.
[14] P. Rinaldo,et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. , 2008, Clinical chemistry.
[15] Julie Polisena,et al. Rapid review programs to support health care and policy decision making: a descriptive analysis of processes and methods , 2015, Systematic Reviews.
[16] David Hailey,et al. Rapid reviews versus full systematic reviews: An inventory of current methods and practice in health technology assessment , 2008, International Journal of Technology Assessment in Health Care.
[17] H. Arksey,et al. Scoping studies: towards a methodological framework , 2005 .
[18] Thomas P. Mechtler,et al. Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[19] T. Zytkovicz,et al. Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program. , 2013, Clinical biochemistry.
[20] D. Parker,et al. Guidance for conducting systematic scoping reviews , 2015, International journal of evidence-based healthcare.
[21] D. Moher,et al. A scoping review of rapid review methods , 2015, BMC Medicine.
[22] Trudy van der Weijden,et al. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol , 2010, Implementation science : IS.
[23] D. Hailey,et al. Health technology assessment in Canada: diversity and evolution , 2007, The Medical journal of Australia.
[24] R. Guerrini,et al. Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential. , 2011, JIMD reports.
[25] G. la Marca,et al. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. , 2008, Rapid communications in mass spectrometry : RCM.
[26] Alexander Tsertsvadze,et al. How to conduct systematic reviews more expeditiously? , 2015, Systematic Reviews.
[27] Phil Edwards,et al. Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records , 2002, Statistics in medicine.
[28] Lisa Hartling,et al. Advancing knowledge of rapid reviews: an analysis of results, conclusions and recommendations from published review articles examining rapid reviews , 2015, Systematic Reviews.